Clinical Trials Logo

Shoulder Fractures clinical trials

View clinical trials related to Shoulder Fractures.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06354894 Recruiting - Clinical trials for Proximal Humeral Fractures

Percutaneous Pinning Versus Plate and Screws for Surgical Fixation of Proximal Humeral Fractures

Start date: November 1, 2020
Phase:
Study type: Observational

The aim of this multicenter nonrandomised study is to prospectively compare the clinical and radiographic results of two different techniques of surgical fixation of proximal humeral fractures: percutaneous pinning versus plate and screws.

NCT ID: NCT06133920 Recruiting - Clinical trials for Proximal Humeral Fracture

Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures

Start date: February 24, 2021
Phase:
Study type: Observational

The purpose of this study is to evaluate compare postoperative range of motion in patients who are given a sling for comfort only and allowed to start early active range of motion compared to patients who are placed in a sling for 4 weeks with passive range of motion only. Once enrolled, the patients will be randomized through computer randomization then placed in paper packets into either the immobilization group or the early range of motion group.

NCT ID: NCT06078865 Recruiting - Clinical trials for Osteoarthritis Shoulder

FX Shoulder Prospective Clinical Study

Start date: March 31, 2021
Phase:
Study type: Observational [Patient Registry]

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

NCT ID: NCT06077942 Recruiting - Clinical trials for Osteoarthritis Shoulder

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Start date: December 6, 2022
Phase:
Study type: Observational

Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.

NCT ID: NCT06062797 Recruiting - Ankle Fractures Clinical Trials

Improving Patient Understanding in Preoperative Informed Consent Process of Trauma Patients Using a Mixed Reality Viewer

Start date: April 18, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to compare a Mixed Reality Viewer in the preoperative informed consent process to standard fracture visualization. The participants population are patients with an indication for surgery of a distal radius fracture, upper ankle fracture or proximal humerus fracture using plate osteosynthesis. The main questions aim to answer are: - Does the use of the Mixed Reality Viewer improve patient understanding? - Does the use of the Mixed Reality Viewer improve patient satisfaction? - Does the use of the Mixed Reality Viewer reduce patient preoperative anxiety? Participants will have their fracture presented via the Mixed Reality Viewer. Researchers will compare standard fracture imaging using X-ray or CT scans to see if there is any difference in understanding, satisfaction and anxiety.

NCT ID: NCT05703958 Recruiting - Clinical trials for Proximal Humeral Fracture

Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up

Start date: April 19, 2023
Phase:
Study type: Observational

The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Proximal Humerus Fracture Plates over time. This study will follow subjects for a period of up to 10 years post-surgery.

NCT ID: NCT05437822 Recruiting - Clinical trials for Proximal Humeral Fracture

Tranexamic Acid in Proximal Humeral Fractures

Start date: June 29, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of tranexamic acid (on blood loss and transfusion requirements in patients with proximal humeral fractures requiring open surgical approaches. This a blinded, controlled, therapeutic trial in which the patients will be randomized to receive TXA or no drug intervention. The primary outcome is the estimated total blood loss. This study presents only minimal risks for the included patients.

NCT ID: NCT05284357 Recruiting - Shoulder Disease Clinical Trials

Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term

Start date: April 7, 2022
Phase:
Study type: Observational

This study takes place in the framework of the Post-Market Clinical Follow-up of the FX Solutions Shoulder System. The goal of this PMCF study is to collect clinical data in order to confirm the safety and the performance at a long term and mainly the first two years of sales for each studied ranges. Eligible patients who received the FX Solutions Shoulder System and are at about 7 years post-operative were contacted by the Investigator to explain the study, the retrospective collection and the prospective follow-up visit. Investigator also explain the analysis of the post-operative outcomes of the patient. During the call of the investigator, the patient was informed about the study's goal and about the data collection. The oral agreement of the patient was checked by the investigators in CRF with its signature. Then, an information form explaining the purpose of the data collection was provided to the patient by postmail. The retrospective data were collected in a paper CRF via the medical file of patient. Post-operative follow-up for all patients is limited to a teleconsultation intended to assess the patient's current condition and clinical outcomes. Patient who are enrolled in the study shall be assigned a unique Subject Identification Number to de-identify their information.

NCT ID: NCT05084573 Recruiting - Shoulder Fractures Clinical Trials

Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery

CLIP-H
Start date: August 1, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of continuous interscalene block (CISB) using standard bupivacaine versus a single interscalene injection of liposomal bupivacaine (LB) on pain control following surgical fixation of proximal humerus fractures.

NCT ID: NCT05019664 Recruiting - Humeral Fractures Clinical Trials

Affixus Natural Nail System Humeral Nail PMCF

Start date: August 29, 2022
Phase: N/A
Study type: Interventional

A commercially available product clinical study which aims to confirm the safety, performance and clinical benefits to the patient of the Affixus Natural Nail upper arm (humerus) bone nail system for both the implant itself and the instrumentation used during surgery.